Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 359 | 1,199 | 195 | 2,049 | 2,686 |
| Inventories | 269 | 460 | 538 | 585 | 480 |
| Other current assets | 632 | 603 | 954 | 1,648 | 1,539 |
| TOTAL | $1,260 | $2,262 | $1,687 | $4,282 | $4,705 |
| Non-Current Assets | |||||
| PPE Net | 63 | 158 | 375 | 633 | 1,123 |
| Intangibles | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $63 | $158 | $375 | $633 | $1,125 |
| Total Assets | $1,323 | $2,420 | $2,062 | $4,915 | $5,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 372 | 283 | 480 | 466 | 344 |
| Other current liabilities | N/A | 19 | N/A | N/A | N/A |
| TOTAL | $623 | $584 | $879 | $1,208 | $996 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 31 | 20 | 20 | 20 | 20 |
| TOTAL | $31 | $43 | $60 | $23 | $87 |
| Total Liabilities | $654 | $627 | $939 | $1,231 | $1,083 |
| Shareholders' Equity | |||||
| Common Shares | 4,197 | 3,815 | 1,040 | 1,040 | 1,024 |
| Retained earnings | -11,467 | -9,765 | -7,564 | -5,003 | -3,824 |
| TOTAL | $669 | $1,793 | $1,123 | $3,684 | $4,747 |
| Total Liabilities And Equity | $1,323 | $2,420 | $2,062 | $4,915 | $5,830 |